Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands
Maxwell D. Cummings, Sivakumar Sekharan
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 15, pp. 6843-6853
Closed Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

A happy medium: the synthesis of medicinally important medium-sized rings via ring expansion
Aimee K. Clarke, William P. Unsworth
Chemical Science (2020) Vol. 11, Iss. 11, pp. 2876-2881
Open Access | Times Cited: 168
Improving Conformer Generation for Small Rings and Macrocycles Based on Distance Geometry and Experimental Torsional-Angle Preferences
Shuzhe Wang, Jagna Witek, Gregory A. Landrum, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 4, pp. 2044-2058
Open Access | Times Cited: 160
Macrocycles in Drug Discovery─Learning from the Past for the Future
Diego García Jiménez, Vasanthanathan Poongavanam, Jan Kihlberg
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5377-5396
Open Access | Times Cited: 128
Pharmacology and Clinical Development of Factor XI Inhibitors
Antonio Greco, Claudio Laudani, Marco Spagnolo, et al.
Circulation (2023) Vol. 147, Iss. 11, pp. 897-913
Open Access | Times Cited: 75
Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
Hao Chen, Jeff B. Smaill, Tongzheng Liu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14404-14424
Closed Access | Times Cited: 75
Ideality in Context: Motivations for Total Synthesis
David S. Peters, Cody Ross Pitts, Kyle S. McClymont, et al.
Accounts of Chemical Research (2021) Vol. 54, Iss. 3, pp. 605-617
Open Access | Times Cited: 61
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
Xiaoshen Ma, David L. Sloman, Ruchia Duggal, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11024-11052
Closed Access | Times Cited: 11
Recent Advances on Targeting Proteases for Antiviral Development
Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva
Viruses (2024) Vol. 16, Iss. 3, pp. 366-366
Open Access | Times Cited: 9
Cyclic Peptide Keap1–Nrf2 Protein–Protein Interaction Inhibitors: Design, Synthesis, and In Vivo Treatment of Acute Lung Injury
Jihua Zou, Jianyu Yan, Yifei Lü, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4889-4903
Closed Access | Times Cited: 8
Directed Evolution of a Modular Polyketide Synthase Thioesterase for Generation of a Hybrid Macrocyclic Ring System
Maria L. Adrover‐Castellano, Brian J. Curtis, Jennifer J. Schmidt, et al.
ACS Catalysis (2025), pp. 3405-3417
Closed Access | Times Cited: 1
An overview of DNA-encoded libraries: A versatile tool for drug discovery
Daniel H. Madsen, Carlos Azevedo, Iolanda Micco, et al.
Progress in medicinal chemistry (2020), pp. 181-249
Closed Access | Times Cited: 67
MacrocyclizationviaC–H functionalization: a new paradigm in macrocycle synthesis
Saumitra Sengupta, Goverdhan Mehta
Organic & Biomolecular Chemistry (2020) Vol. 18, Iss. 10, pp. 1851-1876
Closed Access | Times Cited: 61
Intermolecular Interactions in Functional Crystalline Materials: From Data to Knowledge
Анна В. Вологжанина
Crystals (2019) Vol. 9, Iss. 9, pp. 478-478
Open Access | Times Cited: 54
Cheminformatic analysis of natural product-based drugs and chemical probes
Samantha Stone, David Newman, Steven L. Colletti, et al.
Natural Product Reports (2021) Vol. 39, Iss. 1, pp. 20-32
Open Access | Times Cited: 44
Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors
Michael Bauder, Christian Meyners, Patrick L. Purder, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 6, pp. 3320-3349
Closed Access | Times Cited: 43
Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
Alessandra Salerno, Francesca Seghetti, Jessica Caciolla, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9507-9530
Open Access | Times Cited: 28
Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design
Yang Yu, Junhong Huang, Hu He, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 3, pp. 297-304
Open Access | Times Cited: 21
Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery
Isabela Ramirez-Velez, Brian Belardi
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114905-114905
Open Access | Times Cited: 21
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
Yi‐Ru Bai, Weiguang Yang, Xuehui Hou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115606-115606
Closed Access | Times Cited: 20
Macrocyclization of linear molecules by deep learning to facilitate macrocyclic drug candidates discovery
Yanyan Diao, Dandan Liu, Huan Ge, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
A modular biomimetic strategy for the synthesis of macrolide P-glycoprotein inhibitors via Rh-catalyzed C-H activation
Lu Chen, Haitian Quan, Zhongliang Xu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy
Mingshu Wang, Zhi-Zheng Wang, Zilong Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 611-626
Closed Access | Times Cited: 27
An updated patent review of Nrf2 activators (2020-present)
Ziquan Zhao, Ruitian Dong, Keni Cui, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 1, pp. 29-49
Closed Access | Times Cited: 15
Ring Expansion Strategies for the Synthesis of Medium Sized Ring and Macrocyclic Sulfonamides
Zhongzhen Yang, Illya Zalessky, Ryan G. Epton, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 13
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top